Appendix 편집하기 (부분)

== Prostate cancer TNM staging AJCC UICC 2017 ==
Primary tumor (T)

{| class="wikitable"
! colspan="3" |Clinical T (cT)
|-
!T category
! colspan="2" |T criteria
|-
|TX
| colspan="2" |Primary tumor cannot be assessed
|-
|T0
| colspan="2" |No evidence of primary tumor
|-
|T1
| colspan="2" |Clinically inapparent tumor that is not palpable
|-
|T1a
| colspan="2" |Tumor incidental histologic finding in 5% or less of tissue resected
|-
|T1b
| colspan="2" |Tumor incidental histologic finding in more than 5% of tissue resected
|-
|T1c
| colspan="2" |Tumor identified by needle biopsy found in one or both sides, but not palpable
|-
|T2
| colspan="2" |Tumor is palpable and confined within prostate
|-
|T2a
| colspan="2" |Tumor involves one-half of one side or less
|-
|T2b
| colspan="2" |Tumor involves more than one-half of one side but not both sides
|-
|T2c
| colspan="2" |Tumor involves both sides
|-
|T3
| colspan="2" |Extraprostatic tumor that is not fixed or does not invade adjacent structures
|-
|T3a
| colspan="2" |Extraprostatic extension (unilateral or bilateral)
|-
|T3b
| colspan="2" |Tumor invades seminal vesicle(s
|-
|T4
| colspan="2" |Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall
|-
! colspan="3" |Pathological T (pT)
|-
!T category
! colspan="2" |T criteria
|-
|T2
| colspan="2" |Organ confined
|-
|T3
| colspan="2" |Extraprostatic extension
|-
|T3a
| colspan="2" |Extraprostatic extension (unilateral or bilateral) or microscopic invasion of bladder neck
|-
|T3b
| colspan="2" |Tumor invades seminal vesicle(s)
|-
|T4
| colspan="2" |Tumor is fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, and/or pelvic wall
|-
| colspan="3" |NOTE: There is no pathological T1 classification. NOTE: Positive surgical margin should be indicated by an R1 descriptor, indicating residual microscopic disease.
|-
! colspan="3" |Regional lymph nodes (N)
|-
!N category
! colspan="2" |N criteria
|-
|NX
| colspan="2" |Regional nodes were not assessed
|-
|N0
| colspan="2" |No positive regional nodes
|-
|N1
| colspan="2" |Metastases in regional node(s
|-
| colspan="3" |Distant metastasis (M)
|-
|M1a
| colspan="2" |Nonregional lymph node(s)
|-
|M1b
| colspan="2" |Bone(s)
|-
|M1c
| colspan="2" |Other site(s) with or without bone disease
|-
| colspan="3" |NOTE: When more than one site of metastasis is present, the most advanced category is used. M1c is most advanced.
|-
| colspan="3" |Prostate-specific antigen (PSA)
|-
| colspan="3" |PSA values are used to assign this category.
|-
| colspan="3" |PSA values
|-
| colspan="3" |<10
|-
| colspan="3" |≥10 <20
|-
| colspan="3" |<20
|-
| colspan="3" |≥20
|-
| colspan="3" |Any value
|-
| colspan="3" |Histologic grade group (G)
|-
| colspan="3" |Recently, the Gleason system has been compressed into so-called Grade Groups.
|-
!Grade Group
!Gleason score
!Gleason pattern
|-
|1
|≤6
|≤3+3
|-
|2
|7
|3+4
|-
|3
|7
|4+3
|-
|4
|8
|4+4, 3+5, 5+3
|-
|5
|9 or 10
|4+5, 5+4, or 5+5
|}TNM: tumor, node, metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.